Late Life Generalized Anxiety Disorder

Anxiety disorders do not discriminate by age.

Taxi Japan/Run Photo/Getty Images

Anxiety disorders have historically been thought of as problems of childhood and early adulthood. However, the prevalence of anxiety disorders among older adults ranges from 10% to 20%, making this class of disorders more prevalent than other common late life psychiatric problems such as dementia or depression.

Late Life Onset

The onset of generalized anxiety disorder (GAD) specifically can occur at any point in the life cycle; the average age of onset is 31 years old.

Of all anxiety disorders, however, GAD stands as the most common in late life with estimates in the older adult age group ranging from 1%-7%.

Its prevalence in older adults may in part be reflective of the tenacity of GAD; young adults who struggle with generalized anxiety can experience a recurrence of symptoms in middle and later stages of life. The new onset of GAD among older adults is often related to co-existing depression.

The diagnosis of GAD in late life can be complicated by several factors:

  • Older adults may present their symptoms differently than younger people. They may articulate the physical symptoms of anxiety more readily than the psychological symptoms.
  • The presence of a medical illness (the odds of which increase with age) is a known risk factor for anxiety disorders.
  • Older adults are more likely than younger adults to be taking multiple medications. Because physical symptoms of anxiety may overlap with medication side effects, it’s helpful to pay attention to the triggers and time course of physical symptoms as they relate to medication schedules or changes versus other potential stressors.

    Under-treated in the Elderly

    GAD is unfortunately under-treated in the elderly. Inadequate diagnosis is one reason for this, but another is access or ability to seek out treatment. Among older adults living with this disorder, it is estimated that only approximately one-quarter seek out professional help for their symptoms.

    The first step in a diagnostic evaluation can involve speaking with a current physician – either a primary care physician or a clinician involved in the treatment of an existing medical illness. A referral for a comprehensive evaluation with a mental health provider may follow.

    The treatments available for GAD in younger adults, which include medication and psychotherapy options, have not been studied as comprehensively in randomized controlled trials of older adults. Findings from medication studies for anxiety disorders completed in mixed-age adult samples and the existing trials in older adults generally do support the use medications for anxiety in late life individuals.

    There is also evidence that the psychotherapy approach used to good effect in the treatment of GAD in children and young adults, cognitive behavioral therapy (CBT), is similarly beneficial to older adults. Modifications and enhancements to CBT – for example, using large print educational materials and delivering the treatment in a group format – show promise for even more benefit for this age group.

     To address barriers for treatment including mobility and access, guided self-help approaches derived from CBT principles are also under study.


    Barrowclough C, King P, Colville J, et al. A randomized controlled trial of the effectiveness of cognitive behavioral therapy and supportive counseling for anxiety symptoms in older adults. Journal of Consulting Psychology 2001; 69:756-762.

    Cassidy K, Rector NA. The silent geriatric giant: anxiety disorders in late life. Geriatrics and Aging 2008; 11(3):150-156.

    Hall J, Kellett S, Berrios R, Bains MK, Scott S. Efficacy of cognitive behavioral therapy for generalized anxiety disorder in older adults: systematic review, meta-analysis, and meta-regressionAmerican Journal of Geriatric Psychiatry 2016: Epub ahead of print, June 17, 2016. 

    Lenze E, Mulsant BH, Shear MK et al. Comorbidity of depression and anxiety disorders in later life. Depression and Anxiety 2001; 14:86-93.

    Lenze E, Mulsant BH, Shear MK et al. Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. American Journal of Psychiatry 2005; 162:146-150.

    Mackenzie CS, Reynolds K, Cho, KL, Pagura J, Sareen, J. Prevalence and correlates of generalized anxiety disorder in a national sample of older adults. American Journal of Geriatric Psychiatry 2011; 19: 305-315.

    Wolitzky-Taylor KB, Castriotta N, Lenze, EJ, Stanley MA, Craske MG. Anxiety disorders in older adults: a comprehensive review. Depression and Anxiety 2010; 27(2):190-211.

    Continue Reading